Medhealth Review

Kidney Cancer Drugs Market: A Domain of Gazillion Opportunities A data published by the American Cancer Society; kidney cancer is one of the 10 most common cancers in 10 common cancers in both women and men in the United States. By Aashi Mishra, Research Writer at Research Nester Analytics Read More...https://lnkd.in/gjS5hqQj #medhealthreview #researchnester

Radiopharmaceuticals Market Size Worth USD 26.6 billion by 2037 Research Nester assesses the growth and size of the global radiopharmaceuticals market which is anticipated to account for the increasing prevalence of chronic illnesses, the need for more sophisticated tests and treatments, and the development of diagnostic imaging technology. By Aashi Mishra, Research Writer at Research Nester Analytics Read More...https://lnkd.in/gSDdyxhj #medhealthreview #ResearchNester

Separating Myths from Miracles in Electromagnetic healing Imagine walking through a health expo, surrounded by vendors promising the latest breakthroughs in wellness technology. “Recharge your cells with electromagnetic therapy!” one booth exclaims. “Cure pain instantly with PEMF!” another promises. But is there truth behind these claims? Can Pulsed Electromagnetic Field (PEMF) therapy truly heal the body at a cellular level, or is this just another health trend wrapped in flashy marketing? By Mike Van Thielen, PhD, Owner of Biohacking Unlimited Read More...https://lnkd.in/euCzxf7A #medhealthreview #biohackingunlimited

Telomeres and its functions Telomeres are fascinating structures that play a crucial role in maintaining the integrity of our genetic information. These protective caps, located at the ends of chromosomes, are composed of repetitive DNA sequences and associated proteins. Their primary function is to safeguard the ends of chromosomes from deterioration or fusion with neighboring chromosomes, which can lead to genetic instability and various diseases. By Abdul Alkayali, Vice President of Certified Nutraceuticals Read More...https://lnkd.in/gmGbHnAn #medhealthreview #CertifiedNutraceuticals

Valis Biosciences' Quest to Decode Measurement in Clinical Trials espite Valis’s achievement, their adventure is far from ended. We can’t help but be optimistic about the future as long as they keep coming up with new ideas, working together, and support ing a more sympathetic method of measurement and assessment in clinical trials and research studies. We’re getting closer to a society in which CNS disorders, such as mental illness, and rare and orphan disorders is accept ed with compassion and under standing rather than stigma tised or disregarded with Valis Biosciences leading the way. Christian Yavorsky, Chief Scientific Officer at Valis Bioscience Read More...https://lnkd.in/gGFm2Ayd #medhealthreview #ValisBioscience

An Award-Winning Solution Solving the Biggest Challenges in Clinical Trials In the fast-paced world of clinical trials, efficiency and precision are crucial. At Clinion, we’re proud to lead the charge with innovative technology that’s making a real difference. As someone deeply committed to advancing clinical research, I’m thrilled to share how our award-winning solutions are redefining trial management. By Manuj Vangipurapu, Founder Director at Clinion - eClinical Platform Read More...https://lnkd.in/g2feH2bB #medhealthreview #Clinion

DeepWell DTx announces FDA clearance that draws on video games and other interactive media to treat mental health DeepWell Digital Therapeutics (DTx), which commercializes immersive medical media for mental and physical health, today announced it has received 510(k) clearance from the Food and Drug Administration (FDA) on its biofeedback (ABS) software development kit (SDK) for use in over-the-counter treatments for the reduction of stress and as an adjunctive treatment for high blood pressure, together with other pharmacological and/or nonpharmacological interventions. By Jeffrey Tseng CEO at DeepWell DTx Read More...https://lnkd.in/gnfWZcAk #medhealthreview #deepwelldtx

Inside ProductionToGo’s Cutting-Edge Solutions Among other things, several new and advanced materials from our partners are currently in the f inal stages of the certification process for medical applications and we are already looking forward to offering these solutions to our customers Maximilian Neck, CEO at ProductionToGo GmbH Read More...https://lnkd.in/gGUkhM7x #medhealthreview #ProductionToGo

Reverba: Setting the Trend with Innovative Patient Engagement Strategies We bridge the gap between knowledge and empathy, using our years of experience and compliant high- and low-tech solutions. Cheryl Lubbert, Chief Executive Officer at Reverba Read More...https://lnkd.in/eUhYR3vd #medhealthreview #Reverba

Building Outpatient cashless services. Health insurance coverage for outpatient department (OPD) treatments typically includes medical costs for patients who do not require hospitalisation, such as expenses on consultations, diagnostic tests, and prescription drugs. By Shubhra Singh, Head - Customer Solutions of Medi Assist Read More...https://lnkd.in/gpMADD4c #medhealthreview #mediassist